...
首页> 外文期刊>Journal of vascular and interventional radiology: JVIR >Percutaneous laser ablation in the treatment of hepatocellular carcinoma with small tumors: analysis of factors affecting the achievement of tumor necrosis.
【24h】

Percutaneous laser ablation in the treatment of hepatocellular carcinoma with small tumors: analysis of factors affecting the achievement of tumor necrosis.

机译:经皮激光消融治疗小肿瘤性肝细胞癌:影响肿瘤坏死的因素分析。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

PURPOSE: To identify the factors that affect the achievement of tumor necrosis with percutaneous laser ablation (PLA) in patients with hepatocellular carcinoma (HCC) and tumor size no larger than 4.0 cm. MATERIALS AND METHODS: Ultrasound-guided biopsy results were retrospectively studied in 99 lesions (range, 0.5-4.0 cm; mean, 2.7 cm) from 82 patients (44 men, 38 women; age range, 50-80 years; median, 68 y) who had undergone PLA. RESULTS: Complete tumor ablation was obtained in 90 lesions (90.9%). Of the nine cases in which complete tumor necrosis was not achieved, six had tumors located in sites that did not allow the optimal placement of fibers, and five of these had a tumor diameter greater than 3 cm. Early discontinuation of PLA as a result of decompensation of liver cirrhosis was the reason for not achieving a complete tumor ablation in three other cases. There was a clear relationship between the energy delivered and the volume of necrosis achieved (r = 0.56; P < .001) regardless of the initial size of HCC tumors. The number of illuminations required, and consequently the amount of energy delivered, was also affected by tumor location. In fact, lesions adjacent to large vessels (> or = 3 mm) required a greater number of illuminations than the other lesions to achieve complete ablation (2.9 +/- 1.4 vs 2.3 +/- 0.9; P = .043). The eight cases with undifferentiated histology required more illuminations than the cases with other histologic types (3.4 +/- 0.9 vs 2.2 +/- 0.9; P < .001). However, these cases were located in sites that did not allow the optimal placement of fibers, therefore requiring multiple treatments. CONCLUSION: PLA is a highly effective treatment in HCC with a tumor size of 4.0 cm or smaller. In this setting, two variables, tumor size and tumor location, affect the achievement of complete tumor ablation and the number of treatments required to obtain tumor necrosis.
机译:目的:确定影响肝癌(HCC)且肿瘤大小不大于4.0 cm的患者经皮激光消融(PLA)实现肿瘤坏死的因素。材料与方法:回顾性分析了82例患者(男性44例,女性38例;年龄50-80岁;中位年龄68岁)的99个病灶(范围0.5-4.0 cm;平均2.7 cm)中超声引导下的活检结果。 )谁曾经历过解放军。结果:90个病灶(90.9%)获得了完全的肿瘤消融。在9例未达到完全肿瘤坏死的病例中,有6例的肿瘤位于无法最佳放置纤维的部位,其中5例的肿瘤直径大于3 cm。由于肝硬化失代偿而导致的PLA的早期停用是在其他三例中未实现完全消融的原因。无论HCC肿瘤的初始大小如何,所传递的能量与达到的坏死量之间存在明显的关系(r = 0.56; P <.001)。所需的照明次数以及因此传递的能量数量也受到肿瘤位置的影响。实际上,与其他病变相比,邻近大血管(>或= 3 mm)的病变需要更多的照明才能实现完全消融(2.9 +/- 1.4对2.3 +/- 0.9; P = .043)。与其他组织学类型的病例相比,八个组织学未分化的病例需要更多的照明(3.4 +/- 0.9 vs 2.2 +/- 0.9; P <.001)。然而,这些病例位于不能最佳放置纤维的部位,因此需要多次治疗。结论:PLA是一种有效的治疗HCC的方法,其肿瘤大小为4.0 cm或更小。在这种情况下,肿瘤大小和肿瘤位置这两个变量会影响肿瘤完全消融的实现以及获得肿瘤坏死所需治疗的次数。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号